💨 Abstract

The court adjourned till May 17 the plea filed by the Serum Institute of India (SII) challenging an order of the Bombay High Court. The plea challenged inclusion of subsidy, grant, waivers, concessions or reimbursements by the Centre or states or incentives in cash or kind as ‘income’.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖

Powered by MessengerX.io